Search Results - Jeffrey C. Yu
- Showing 1 - 4 results of 4
-
1
Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials by Jeffrey C. Yu, Jakub P. Hlávka, Elizabeth Joe, Frances J. Richmond, Darius N. Lakdawalla
Published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (2022-01-01)Get full text
Article -
2
Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospe... by Elizabeth A. Griffiths, Jae S. Min, Wei-Nchih Lee, Jeffrey C. Yu, Yogesh Patel, Karl-Johan Myren, David Dingli
Published in Health and Quality of Life Outcomes (2024-08-01)Get full text
Article -
3
Correction: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder by Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey C. Yu, Jeroen Jansen, Ina Zhang
Published in Neurology and Therapy (2024-06-01)Get full text
Article -
4
Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder by Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey C. Yu, Jeroen Jansen, Ina Zhang
Published in Neurology and Therapy (2024-05-01)Get full text
Article